NextCure, Inc. (NXTC)
13.73
-0.54
(-3.78%)
USD |
NASDAQ |
Feb 20, 16:00
14.09
+0.36
(+2.62%)
After-Hours: 20:00
NextCure Shareholders Equity (Quarterly) : 23.65M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 94.39M |
| BioMarin Pharmaceutical, Inc. | 6.057B |
| Imunon, Inc. | 4.082M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 39.61M |
| Total Liabilities (Quarterly) | 15.97M |
| Debt to Equity Ratio | 0.2007 |
| Current Ratio | 2.969 |
| Net Debt Paydown Yield | 1.80% |